Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SCN8A | Q9UQD0 | 2/20 | 0.38 |
| ▸ | SCN10A | Q9Y5Y9 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PNLIP | P16233 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.37 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.37 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7861651 | 0.83 | KMT2A (0.55) | KMT2AALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL9948495 | 0.80 | CYP1A2 (0.54) | KMT2AALDH1A1CYP3A4PNLIPTP53 | |
| SCHEMBL6447800 | 0.76 | TTR (0.56) | KMT2AALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL364764 | 0.74 | ALDH1A1 (0.65) | KMT2AALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL3691064 | 0.73 | KMT2A (0.61) | KMT2AALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL3045049 | 0.71 | KMT2A (0.52) | KMT2AALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL11786141 | 0.70 | KMT2A (0.51) | KMT2AALDH1A1MAPTNPC1RAB9A | |
| SCHEMBL29089181 | 0.70 | PNLIP (0.50) | KMT2AALDH1A1MAPTSCN8ASCN10A | |
| SCHEMBL363918 | 0.69 | ALDH1A1 (0.65) | ALDH1A1MAPTRAB9ACYP3A4KDM4E | |
| SCHEMBL29518159 | 0.69 | ALDH1A1 (0.65) | ALDH1A1MAPTRAB9ACYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090209608-A1 | DEUTERIUM-ENRICHED ASENAPINE | PROTIA, LLC (US) | 2009-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209608-A1 | DEUTERIUM-ENRICHED ASENAPINE | NSD2, DRD2, SNRPD2 | KMT2A 1823/4885ALDH1A1 1644/4885MAPT 1733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.